<html>
<head>PUBMED IDs for CPG2</head>
<body bgcolor='#C5F0F2'><h1>CPG2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8840992/'>Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination.</a> October 15  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9415889/'>A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy.</a> January 7  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10395490/'>Self-immolative anthracycline prodrugs for suicide gene therapy.</a> July 8  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10680842/'>Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effect.</a> February 19  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11059693/'>In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrug.</a> November 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11360829/'>Clinical applications of phage-derived sFvs and sFv fusion proteins.</a> May 22  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11360823/'>Application of scFv-phage display to analysis of B-cell clones proliferating in the salivary glands of a patient with Sj√∂gren's syndrome.</a> May 22  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11912146/'>Three new prodrugs for suicide gene therapy using carboxypeptidase G2 elicit bystander efficacy in two xenograft models.</a> March 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12386828/'>Adenovirus vector-mediated delivery of the prodrug-converting enzyme carboxypeptidase G2 in a secreted or GPI-anchored form: High-level expression of this active conditional cytotoxic enzyme at the plasma membrane.</a> October 19  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12699387/'>Self-immolative nitrogen mustards prodrugs cleavable by carboxypeptidase G2 (CPG2) showing large cytotoxicity differentials in GDEPT.</a> April 18  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14529410/'>Prodrugs in genetic chemoradiotherapy.</a> October 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15093733/'>Enaptin, a giant actin-binding protein, is an element of the nuclear membrane and the actin cytoskeleton.</a> April 20  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15115406/'>Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.</a> April 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15541315/'>CPG2: a brain- and synapse-specific protein that regulates the endocytosis of glutamate receptors.</a> November 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15958540/'>Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2.</a> June 17  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16078849/'>Novel fluorinated prodrugs for activation by carboxypeptidase G2 showing good in vivo antitumor activity in gene-directed enzyme prodrug therapy.</a> August 5  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16290933/'>Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy.</a> November 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17510425/'>Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2.</a> May 19  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19259950/'>A novel technique to monitor carboxypeptidase G2 expression in suicide gene therapy using 19F magnetic resonance spectroscopy.</a> August 13  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20891022/'>Noninvasive detection of carboxypeptidase G2 activity in vivo.</a> May 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/24191017/'>Regulation of glutamate receptor internalization by the spine cytoskeleton is mediated by its PKA-dependent association with CPG2.</a> January 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26704904/'>Genomic mapping and cellular expression of human CPG2 transcripts in the SYNE1 gene.</a> November 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26776730/'>CPG2 Recruits Endophilin B2 to the Cytoskeleton for Activity-Dependent Endocytosis of Synaptic Glutamate Receptors.</a> November 8  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26894679/'>The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine.</a> July 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26894651/'>A candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantation.</a> September 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28434412/'>Molecular characterization and transcriptional analysis of the female-enriched chondroitin proteoglycan 2 of Toxocara canis.</a> April 25  2017<br></body></html>
